Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 7/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.62 |
| ▸ | MAPT | P10636 | 4/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.62 |
| ▸ | HPGD | P15428 | 3/20 | 0.62 |
| ▸ | TSHR | P16473 | 3/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | CFTR | P13569 | 3/20 | 0.56 |
| ▸ | GLA | P06280 | 2/20 | 0.51 |
| ▸ | CASP1 | P29466 | 1/20 | 0.51 |
| ▸ | CASP7 | P55210 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | ABL1 | P00519 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA7 | P43166 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7101138 | 0.98 | GAA (0.60) | GAAALDH1A1KDM4EMAPTHSD17B10 | |
| Ammonia Solution, Strong SCHEMBL18151874 | 0.98 | GAA (0.60) | GAAALDH1A1KDM4EMAPTHSD17B10 | |
| SCHEMBL1184918 | 0.85 | ALDH1A1 (0.66) | GAAALDH1A1KDM4EMAPTHSD17B10 | |
| SCHEMBL15326189 | 0.82 | CA12 (0.50) | GAAALDH1A1KDM4EMAPTHSD17B10 | |
| SCHEMBL31585831 | 0.82 | CA12 (0.50) | GAAALDH1A1KDM4EMAPTHSD17B10 | |
| SCHEMBL7529190 | 0.81 | KDM4E (0.66) | GAAALDH1A1KDM4EMAPTHSD17B10 | |
| SCHEMBL6168887 | 0.81 | GAA (0.66) | GAAALDH1A1KDM4EMAPTHSD17B10 | |
| SCHEMBL1277539 | 0.81 | CA12 (0.44) | GAAALDH1A1KDM4EMAPTHSD17B10 | |
| SCHEMBL6351877 | 0.81 | GABRG2 (0.43) | GAAALDH1A1KDM4EMAPTHSD17B10 | |
| SCHEMBL5621223 | 0.81 | ALDH1A1 (0.60) | GAAALDH1A1KDM4EMAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 239 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117821982-A | Thiourea modified imidazoline corrosion inhibitor and preparation method thereof | 沧州中润化学助剂有限公司 | 2024-04-05 | — | — | CN | claimed |
| EP-1344775-A1 | Preparation of fungicidal quinazolinones and useful intermediates | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-09-17 | — | — | EP | claimed |
| US-6166208-A | Preparation of fungicidal quinazolinones and useful intermediates | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-12-26 | — | — | US | claimed |
| EP-0922037-A1 | PREPARATION OF FUNGICIDAL QUINAZOLINONES AND USEFUL INTERMEDIATES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-06-16 | — | — | EP | claimed |
| WO-1997048684-A1 | PREPARATION OF FUNGICIDAL QUINAZOLINONES AND USEFUL INTERMEDIATES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-12-24 | — | — | WO | claimed |
| US-12577227-B2 | WDR5 inhibitors and modulators | VANDERBILT UNIVERSITY (US) | 2026-03-17 | — | — | US | disclosed |
| CN-119874668-A | Main protease regulator and application thereof | 北京昌平实验室 | 2025-04-25 | — | — | CN | disclosed |
| CN-119684383-A | Compositions and methods for chemical cleavage and deprotection of surface-bound oligonucleotides | 伊鲁米纳公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-111065645-B | Compositions and methods for chemical cleavage and deprotection of surface-bound oligonucleotides | 伊鲁米纳公司 | 2024-12-31 | — | — | CN | disclosed |
| CN-119080751-A | Heterocyclic aza-diketone derivative and preparation method and application thereof | 山东大学 | 2024-12-06 | — | — | CN | disclosed |
| US-20240400605-A1 | COMPOSITIONS AND METHODS FOR CHEMICAL CLEAVAGE AND DEPROTECTION OF SURFACE-BOUND OLIGONUCLEOTIDES | ILLUMINA CAMBRIDGE LIMITED (GB) | 2024-12-05 | — | — | US | disclosed |
| US-12084474-B2 | Compositions and methods for chemical cleavage and deprotection of surface-bound oligonucleotides | ILLUMINA, INC. (US) | 2024-09-10 | — | — | US | disclosed |
| WO-1997048684-A1 | PREPARATION OF FUNGICIDAL QUINAZOLINONES AND USEFUL INTERMEDIATES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-12-24 | — | — | WO | disclosed |
| EP-0147211-B1 | 4H-3,1-BENZOXAZIN-4-ONES AND RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION | SYNTEX (U.S.A.) INC. (US) | 1990-09-12 | — | — | EP | disclosed |
| US-4710507-A | Quinolone inotropic agents | PFIZER INC. (US) | 1987-12-01 | — | — | US | disclosed |
| US-4657893-A | ANTIINFLAMMATORY AGENTS | SYNTEX (U.S.A.) INC. (US) | 1987-04-14 | — | — | US | disclosed |
| EP-0148623-A2 | Quinolone inotropic agents | Pfizer Limited (GB) | 1985-07-17 | — | — | EP | disclosed |
| EP-0147211-A2 | 4H-3,1-benzoxazin-4-ones and related compounds, pharmaceutical compositions containing them, and processes for their preparation | SYNTEX (U.S.A.) INC. (US) | 1985-07-03 | — | — | EP | disclosed |
| US-4242121-A | USING A PHENOXYBENZOIC ACID, ITS ESTER OR SALT | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1980-12-30 | — | — | US | disclosed |
| US-4000275-A | BENZIMIDAZO(2,1-B) QUINAZOLIN-12(6H)ONES | ELI LILLY AND COMPANY (US) | 1976-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12084474-B2 | Compositions and methods for chemical cleavage and deprotection of surface-bound oligonucleotides | SNRPB2, NUDT21, DNMT3B | GAA 1053/4885ALDH1A1 4476/4885KDM4E 3101/4885 |
| US-12577227-B2 | WDR5 inhibitors and modulators | WDR1, WDR5, WDR3 | GAA 4580/4885ALDH1A1 2812/4885KDM4E 1609/4885 |
| US-20240400605-A1 | COMPOSITIONS AND METHODS FOR CHEMICAL CLEAVAGE AND DEPROTECTION OF SURFACE-BOUND OLIGONUCLEOTIDES | SNRPB2, NUDT21, DNMT3B | GAA 1053/4885ALDH1A1 4476/4885KDM4E 3101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.